Overview on the effects of progestins on bone

Area of Science:

• Gerontology
• Endocrinology
• Orthopedics

Background:

• Fractures are critical clinical events, necessitating a focus on their risk factors.
• Bone mineral density (BMD) is less critical for severe hip fractures than fall risk.
• Limited experimental data exists on hormone effects and fractures in advanced age.

Purpose of the Study:

• To review the effects of progestins on bone health.
• To evaluate the role of progestins in fracture risk and bone protection.

Main Methods:

• In vitro experiments using cell lines to study progestin effects on bone.
• Clinical observations and prospective studies on progestin use in various contexts.
• Analysis of data from oral contraceptives, depot injections, add-back therapy, and hormone replacement therapy (HRT).

Main Results:

• Progestins used in clinical practice do not demonstrate significant bone-protective effects.
• Progestins do not exhibit estrogen-antagonistic activity impacting bone.
• The influence of progestins on estrogen's bone-protective actions is minimal.

Conclusions:

• Progestins have a negligible impact on bone health, neither protecting nor antagonizing estrogen's effects.
• Fall risk is a more significant factor for hip fractures than bone mineral density.
• Further research may be needed to fully elucidate hormone interactions with bone in aging populations.